Pill Pill lead Pill
Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features
Twitter ~ Facebook
Home / Technology News / 2010 / September 2010 / September 30, 2010
How HRT and the Pill can lead to breast cancer
RSS / Print / Comments

Contraceptive pill

How HRT and the Pill can lead to breast cancer

Now, girls as young as 13 can get 'the Pill' without prescription in UK

The Pill may boost womens social skills and memory

More on Contraceptive pill

Hormone Replacement Therapy

10 tips to steer clear of breast cancer

How HRT and the Pill can lead to breast cancer

Withdrawing HRT from women cuts breast cancer risk, shows study

More on Hormone Replacement Therapy

Breast cancer

Sysmex Announces Establishment of Overseas Subsidiary in Spain to Expand Life Science Business

Breast cancer multigene test may help patients avoid chemo

Mangoes may protect against breast, colon cancer

More on Breast cancer

Technology News

Study to find whether leptin helps type 1 diabetic patients
To determine whether adding the hormone leptin to standard insulin therapy might help rein in the tumultuous blood-sugar levels of people with type 1 (insulin-dependent) diabetes, a clinical trial at UT Southwestern Medical Center is being carried out. ANI

Why deaf have 'super vision'
Researchers have found reasons for the enhanced abilities in the remaining senses of deaf people. ANI

Tsunami risk higher than expected in LA, other major cities
A new study has revealed that the risk of destructive tsunamis is in places such as Kingston, Istanbul, and Los Angeles. ANI

How HRT and the Pill can lead to breast cancer

Synthetic sex hormones called progestins used in hormone replacement therapy, HRT, and in contraceptives can increase the risk of breast cancers, say experts.


London, Sep 30 : Synthetic sex hormones called progestins used in hormone replacement therapy, HRT, and in contraceptives can increase the risk of breast cancers, say experts.

And now medical researchers at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences in Vienna have identified a key mechanism that allows these synthetic sex hormones to directly affect mammary cells.

The research team shows that a synthetic female sex hormone used in HRT and contraceptive pills can trigger RANKL, the master regulator of healthy bones, in breast cells of mice. As a consequence, these mammary cells start to divide and multiply and fail to die when they should. Moreover, stem cells in the breast become able to renew themselves, ultimately resulting in breast cancer.

In a different set of mouse treatment tests, researchers at Amgen have found that pharmacologic blocking of the RANKL system significantly delays mammary tumor formation leading to significantly fewer breast cancers in mice. In another mouse model, RANKL inhibition not only decreased breast tumor formation but also reduced lung metastasis.

"I have to admit it completely surprised me just how massive the effects of the system were. Millions of women take progesterone derivatives in contraceptives and for hormonal replacement therapy.

Since our results show that the RANKL system is an important molecular link between a synthetic sex hormone and breast tumors, one day women may be able to reduce their risk by taking blocking medicines in advance to prevent breast cancer," Nature quoted Prof Josef Penninger as saying.

A monoclonal antibody, denosumab, that blocks RANKL has been recently approved in the US and the EU for the treatment of osteoporosis, and is currently under review for the treatment of bone metastases in patients with advanced cancer.

This scientific article has been published on Nature's website.

ANI

Link to this page

Suggested pages for your additional reading
AndhraNews.net on Facebook






© 2000-2017 AndhraNews.net. All Rights Reserved and are of their respective owners.
Disclaimer, Terms of Service & Privacy Policy | Contact Us